ANNX - Annexon Biosciences Profit before interest, taxes and amortization
Annexon, Inc. (ANNX) is completing final trials for ophthalmology and autoimmune pathology drugs. The EBITDA timeline on GURU.Markets reflects current operational strength, where 0.00 determines the current value of the metric. Looking ahead, the blocking of the C1q protein will protect developments from analogs, while low mass-production costs for tablets will ensure the company achieves long-term monopoly profits in the global market.
Annexon - analytical breakdowns and key metrics (ANNX)
- share price and expert price forecast:
- market capitalization statistics:
- book capitalization data:
- company total debt and liquidity indicators:
Debt to Equity Ratio Annexon, Inc.|ANNX - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Annexon Biosciences|ANNX - Company Aggregate Debts|Debts to Net Assets Annexon|ANNX - Company Long-Term Debt|Company Short-Term Indebtedness Annexon|Quick Liquidity Indicator annexonbio.com
- earnings and valuation multiples indicators:
ANNX - Net Income|Company Profit Forecast Annexon, Inc.|ANNX - P/E Multiple|Forward P/E Multiple annexonbio.com|ANNX - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Annexon|ANNX - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Annexon|ANNX - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last 12 months annexonbio.com|ANNX - Earnings per share growth in current year|Projected earnings per share growth rate for next year Annexon, Inc.
Summary company analytics:ANNX Annexon Biosciences Inc.
For the science-driven Annexon, Inc. (ANNX), which invests in the development of complement inhibitors, EBITDA reflects the actual cash flow from core operations, stripped of non-cash revaluations. Analyzing the baseline EBITDA allows for an assessment of the company's ability to fund costly research and retain academic personnel, where any sharp decline in the indicator signals a critical reduction in business resilience to liquidity shocks.
Competitors of Annexon, Inc. (ANNX)
BIIB: Operating profit before amortization|Neurocrine Biosciences - Operating profit EBITDA|Profit before interest, taxes and amortization regencellbioscience.com|AXSM (Axsome Therapeutics, Inc.) - Operating profit before deduction of amortization|Operating profit before amortization ACAD|Profit before payment of interest, taxes and amortization Xenon Pharmaceuticals Inc|Profit before interest, taxes and amortization Viking Therapeutics Corp VKTX|Profit before payment of interest, taxes and amortization Supernus Pharmaceuticals (SUPN)|catalystpharma.com - Operating profit before amortization|Denali Therapeutics Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization HRMY|Biohaven Pharmaceutical - Operating profit EBITDA|Operating income before deduction of amortization Amylyx Corp AMLX|Trevi Therapeutics (TRVI) - Profit before payment of interest, taxes and amortization|Operating profit before amortization PRAX|AVXL (Anavex Life Sciences Corp.) - Operating profit EBITDA|Operating profit before deduction of amortization CeriBell Inc (CBLL)|Operating profit before deduction of amortization PRTA (Prothena Corp)|Operating income before deduction of amortization alector.com|Operating profit EBITDA OMER (Omeros)|Operating profit EBITDA neurogene.com NGNE|ACIU - Profit before payment of interest, taxes and amortization|VYGR (Voyager Therapeutics Inc) - Operating profit before amortization|Neumora Therapeutics Inc (NMRA) - Profit before payment of interest, taxes and amortization|Operating profit before amortization SCLX|Operating profit before deduction of amortization TVGN|Operating profit before amortization ACOG (Alpha Cognition Corp)|Profit before payment of interest, taxes and amortization Cognition Therapeutics, Inc. (CGTX)|Inhibikase Therapeutics Inc - Operating profit before amortization|Operating profit EBITDA SAVA (Cassava)|Assertio Holdings (ASRT) - Profit before interest, taxes and amortization|COYA: Operating profit before deduction of amortization|VTGN - Operating profit EBITDA|ovidrx.com (OVID) - Profit before payment of interest, taxes and amortization|Acumen Pharmaceuticals Inc. - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization CervoMed Inc|Profit before interest, taxes and amortization Alterity Therapeutics Ltd ATHE|Operating profit EBITDA CLNN|Operating profit EBITDA pepgen.com (PEPG)|Profit before payment of interest, taxes and amortization Jupiter Neurosciences JUNS|RLMD: Operating profit before amortization|ANVS - Profit before payment of interest, taxes and amortization|GRCE (Grace Therapeutics, Inc.) - Operating profit before amortization|AIFF: Operating profit EBITDA|Profit before interest, taxes and amortization Klotho Neurosciences (KLTO)|Operating profit before deduction of amortization NRSN|Operating profit before amortization RVPH (Reviva Pharmaceuticals Holdings Inc.)|Profit before payment of interest, taxes and amortization MetaVia Inc (MTVA)|NRXS - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Helius Medical Technologies HSDT|PASG: Operating profit before amortization|NEUP: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization NERV (Minerva Neurosciences Inc)|ATHA: Operating profit EBITDA|ADXN - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Alzamend Neuro Inc.|Operating profit before amortization CYCN (Cyclerion)|Operating profit EBITDA PTIX|Operating profit before deduction of amortization pasitheaclinics.com KTTA|Cortigent - Operating profit before deduction of amortization|Operating income before deduction of amortization Avenue Therapeutics Inc (ATXI)|Brainstorm Cell - Operating profit EBITDA|CARA - Operating profit EBITDA|Chromocell Therapeutics Corp. (CHRO) - Profit before payment of interest, taxes and amortization|Operating profit before amortization ELYM|Profit before payment of interest, taxes and amortization Intra-Cellular Therapies Inc.|Operating profit before amortization LBPH (Longboard)|Operating profit before deduction of amortization MRNS (Marinus Pharmaceuticals)|nkgenbiotech.com - Operating profit before amortization|Profit before payment of interest, taxes and amortization NeuroBo Pharmaceuticals, Inc. NRBO|SAGE: Operating profit before amortization|Neurotrope - Operating profit EBITDA|Profit before interest, taxes and amortization Trevena Inc|VIGL (vigilneuro.com) - Operating profit before deduction of amortization|anewmeds.com (WENA) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Cerevel Therapeutics, Inc.
